Assignee
RISE BIOPHARMACEUTICALS INC
CN·3 granted patents·1 pending application·0 citations·filing 2020–2022
Top patents by PatentIndex Score
4 records- 0154US12472227B2Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapyRISE BIOPHARMACEUTICALS INC·Filed 2021·Granted Nov 18, 2025·0 cites·3 claims
- 0252US12329804B2Modified chemokine peptide and use thereofRISE BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 17, 2025·0 cites·4 claims
- 0350US2025250298A1Oncolytic peptide and use thereofRISE BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0445US12226454B2Pharmaceutical compositions and use thereof for relieving anticancer drug resistance and enhancing sensitivity of anticancer drugRISE BIOPHARMACEUTICALS INC·Filed 2020·Granted Feb 18, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when RISE BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →